Clinical Trials Logo

Clinical Trial Summary

Objectives: To investigate the outcomes of fenestration decompression combined with secondary curettage (FDSC) in the surgical treatment of jaw ameloblastoma. Methods: Medical records of patients diagnosed as multicystic ameloblastoma (MA) or unicystic ameloblastoma (UA) by routine pathology were collected from January 2010 to December 2017 in Ninth People's Hospital, Shanghai JiaoTong University Medical College. Patients were divided into two groups based on the management regimen: FDSC group, and local curettage (LC) group. Patients were followed up for 3-8 years, using panoramic radiography to measure the change of the area of the cystic cavity involved in ameloblastoma and the recurrence or malignant transformation of the tumor in both groups. A total of 233 eligible patients were selected for provisional screening, including 145 patients with MA, and 88 patients with UA.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04987515
Study type Observational
Source Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Contact
Status Completed
Phase
Start date January 1, 2010
Completion date July 1, 2021